戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  known mutations and sulfonylurea therapy in neonatal diabetes mellitus.
2 ns associated with beta-cell dysfunction and neonatal diabetes mellitus.
3          Mutations that impair folding cause neonatal diabetes mellitus.
4 in secretion as the major cause of permanent neonatal diabetes mellitus.
5 is of the spectrum of disorders constituting neonatal diabetes mellitus.
6 gression of disease states such as transient neonatal diabetes mellitus.
7 expressed gene or genes that cause transient neonatal diabetes mellitus.
8 lso be considered in patients with transient neonatal diabetes mellitus.
9 to a reduction in ATP inhibition and thereby neonatal diabetes mellitus.
10  with fetal growth retardation and transient neonatal diabetes mellitus.
11 ld be tested for in adults with a history of neonatal diabetes mellitus.
12         To date, all patients with transient neonatal diabetes mellitus and uniparental disomy have h
13 for rarely occurring transient and permanent neonatal diabetes mellitus, and transgenic animal models
14 chromosome 10p13-p12.1 involved in permanent neonatal diabetes mellitus associated with pancreatic an
15 types in a cohort of patients diagnosed with neonatal diabetes mellitus before age 1 year, without be
16 utations (Y330C, F333I) that cause permanent neonatal diabetes mellitus, by heterologous expression i
17 t of ATP and are now the primary therapy for neonatal diabetes mellitus caused by mutations in the ge
18 ions, Y330C and F333I, which cause permanent neonatal diabetes mellitus, disrupt this motif and abrog
19 ently, a transgenic mouse model of transient neonatal diabetes mellitus due to mutations in ZAC/HYMAI
20               A new mouse model of transient neonatal diabetes mellitus emphasizes that both the numb
21          To determine whether human X-linked neonatal diabetes mellitus, enteropathy and endocrinopat
22                                    Transient neonatal diabetes mellitus has been associated with abno
23                                              Neonatal diabetes mellitus is a rare genetic form of pan
24                                              Neonatal diabetes mellitus is often associated with neur
25                                     Although neonatal diabetes mellitus is rare, its molecular basis
26 etes (DEND) syndrome, the most severe end of neonatal diabetes mellitus, is caused by mutation in the
27                                              Neonatal diabetes mellitus (NDM) can be caused by gain-o
28 iants in ONECUT1 were reported as a cause of neonatal diabetes mellitus (NDM) in two subjects, and mi
29   This was demonstrated in a murine model of Neonatal Diabetes Mellitus (NDM) involving expression of
30                                              Neonatal diabetes mellitus (NDM) is a rare form of diabe
31 xcitability and undersecretion, resulting in neonatal diabetes mellitus (NDM).
32 in of function mutations in KCNJ11 can cause neonatal diabetes mellitus (NDM).
33                                 Remission of neonatal diabetes mellitus occurred in 89 (51%) index pa
34  molecular mechanisms underlying permanenent neonatal diabetes mellitus (PNDM) in a patient with a he
35 (+) channel (K(ATP) channel) cause permanent neonatal diabetes mellitus (PNDM) in humans.
36                                    Permanent neonatal diabetes mellitus (PNDM) is caused by reduced b
37 n the insulin (INS) gene may cause permanent neonatal diabetes mellitus (PNDM).
38 nts from 20 countries referred to the French Neonatal Diabetes Mellitus Study Group from 1995 to 2010
39                                    Transient neonatal diabetes mellitus (TNDM) is a rare disease char
40                                    Transient neonatal diabetes mellitus (TNDM) is a rare disorder ass
41                                    Transient neonatal diabetes mellitus (TNDM) is a rare form of chil
42                                    Transient neonatal diabetes mellitus (TNDM) is associated with int
43                                    Transient neonatal diabetes mellitus (TNDM) is diagnosed in the fi
44 ted the localization of a gene for transient neonatal diabetes mellitus (TNDM), a rare form of childh
45 eved to underlie the rare disorder transient neonatal diabetes mellitus (TNDM).
46                   Individuals with permanent neonatal diabetes mellitus usually present within the fi
47 duce the sensitivity of ATP inhibition cause neonatal diabetes mellitus via suppression of beta-cell
48  channel subunit (Kir6.2 and SUR1) result in neonatal diabetes mellitus, whereas loss-of-function mut